MedPath

Hemolate

Brand Name: Hemolate

Generic Name: Heparin Sodium

Active
Registration Number

BRP-039-01

Dosage Form

Solution for Injection (IV/SC)

Issuance Date

March 10, 2024

Expiry Date

January 2, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5000 IU/ mL (25000 IU/mL)
Packaging5 mL USP Type I amber glass vial / (Box of 10's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Anticoagulant
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Heparin SodiumActive
Monograph: Heparin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform